Among the fifteen variants, only one (rs10486567 in JAZF1) shared association with prostate cancer in 5,747 African (OR=0.855, 95% c.i.=0.787–0.929) and in 19,461 Caucasian (OR=0.847, 95% c.i.=0.808–0.889) (Figure 1, Supplementary Table S3 and Supplementary Figure S6). Here, JAZF1 is linked to prostate cancer.